정밀 종양학 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품 유형별, 암 유형별, 최종사용자 지역별, 경쟁별 세분화(2020-2030년)
Precision Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Cancer Type, By End User Region and Competition, 2020-2030F
상품코드:1886415
리서치사:TechSci Research
발행일:2025년 12월
페이지 정보:영문 183 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 정밀 암 치료 시장은 2024년에 994억 5,000만 달러로 평가되며, 2030년까지 CAGR 9.12%로 성장하며, 1,678억 7,000만 달러에 달할 것으로 예측됩니다. 정밀 종양학은 개별 종양의 유전자 및 분자 프로파일을 기반으로 암 치료를 맞춤화하고, 특정 암세포의 취약성을 표적으로 삼아 보다 효과적이고 부작용이 적은 치료를 목표로 합니다. 시장의 성장은 종합적인 분자 프로파일링을 가능하게 하는 유전체 시퀀싱 기술의 지속적인 발전과 암 유전체학에 대한 이해도가 높아짐에 따라 근본적으로 촉진되고 있습니다. 또한 전 세계에서 암 발병률이 증가함에 따라 정밀하고 개인화된 치료법에 대한 수요가 크게 증가하고 있습니다.
시장 개요
예측 기간
2026-2030
시장 규모 : 2024년
994억 5,000만 달러
시장 규모 : 2030년
1,678억 7,000만 달러
CAGR : 2025-2030년
9.12%
가장 빠르게 성장하는 부문
유방암
최대 시장
북미
주요 시장 성장 촉진요인
세계 정밀 종양학 시장은 크게 두 가지 요인에 의해 크게 영향을 받고 있습니다. 전 세계에서 증가하는 암 부담과 유전체 시퀀싱 및 분자진단의 지속적인 기술 발전이 그것입니다. 전 세계에서 암 발생률과 사망률이 증가함에 따라 보다 효과적이고 맞춤 치료 전략을 필요로 하는 환자 수가 급증하고 있으며, 이는 중요한 과제로 대두되고 있습니다.
주요 시장 과제
맞춤형 치료의 개발 및 시행에 따른 높은 비용과 환자 접근성 및 보험 상환에 대한 지속적인 장벽의 복잡한 상호작용이 세계 정밀 종양학 시장의 성장을 저해하는 요인으로 작용하고 있습니다. 개인맞춤형 치료의 장점에도 불구하고 막대한 경제적 부담으로 인해 보급에 어려움을 겪고 있으며, 자격을 갖춘 환자들이 이러한 첨단 치료법을 받을 수 있는 기회를 제한하고 있습니다.
주요 시장 동향
종합적인 환자 프로파일링을 위한 멀티오믹스 통합은 암을 보다 종합적으로 이해하는 방향으로 나아가는 중요한 전환점입니다. 이 동향에서는 유전체학, 단백질체학, 전사체학, 대사체학 데이터를 통합하여 개별 종양의 종합적인 분자 설계도를 작성합니다.
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 정밀 종양학 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
제품 유형별(진단약, 치료제)
암 유형별(유방암, 자궁경부암, 전립선암, 폐암)
최종사용자별(병원·진단 검사 기관 , 제약·바이오테크놀러지 기업, 의료 데이터 기업)
지역별
기업별(2024)
시장 맵
제6장 북미의 정밀 종양학 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 정밀 종양학 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 정밀 종양학 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 정밀 종양학 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 정밀 종양학 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병·인수
제품 출시
최근 동향
제13장 세계의 정밀 종양학 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Thermo Fisher Scientific Inc.
Invitae Corporation
Qiagen N.V.
Illumina, Inc.
Laboratory Corporation Of America Holding
Exact Sciences Corporation
Rain Oncology Inc.
Strata Oncology, Inc.
Xilis Inc.
Variantyx, Inc.
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Precision Oncology Market , valued at USD 99.45 Billion in 2024, is projected to experience a CAGR of 9.12% to reach USD 167.87 Billion by 2030. Precision oncology tailors cancer treatment based on an individual's tumor genetic and molecular profiles, aiming for therapies that are more effective and reduce adverse effects by targeting specific cancer cell vulnerabilities. The market's growth is fundamentally driven by continuous advancements in genomic sequencing technologies, which enable comprehensive molecular profiling, alongside a deepening understanding of cancer genomics. Additionally, the escalating global prevalence of cancer significantly increases the demand for precise and individualized treatment options.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 99.45 Billion
Market Size 2030
USD 167.87 Billion
CAGR 2025-2030
9.12%
Fastest Growing Segment
Breast Cancer
Largest Market
North America
Key Market Drivers
The global precision oncology market is significantly influenced by two primary drivers: the escalating worldwide burden of cancer and continuous technological progress in genomic sequencing and molecular diagnostics. The rising global cancer incidence and mortality rates present a critical and expanding patient population in need of more effective and individualized therapeutic strategies.
Key Market Challenges
The complex interaction of high costs associated with developing and administering personalized therapies, coupled with persistent barriers in patient access and reimbursement, significantly impedes the growth of the Global Precision Oncology Market. Despite the inherent benefits of tailored treatments, the substantial financial burden often deters widespread adoption, limiting the ability of eligible patients to receive these advanced solutions. This challenge is further exacerbated by operational inefficiencies and a limited understanding of biomarker strategies among various healthcare stakeholders.
Key Market Trends
Multi-omics integration for comprehensive patient profiling represents a pivotal shift towards a more holistic understanding of cancer. This trend involves combining data from genomics, proteomics, transcriptomics, and metabolomics to create an exhaustive molecular blueprint of an individual's tumor. Such detailed profiling enables clinicians to identify complex disease mechanisms, pinpoint actionable targets with greater precision, and predict therapeutic responses more effectively, ultimately leading to highly individualized treatment strategies.
Key Market Players
Thermo Fisher Scientific Inc.
Invitae Corporation
Qiagen N.V.
Illumina, Inc.
Laboratory Corporation Of America Holding
Exact Sciences Corporation
Rain Oncology Inc.
Strata Oncology, Inc.
Xilis Inc.
Variantyx, Inc.
Report Scope:
In this report, the Global Precision Oncology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Precision Oncology Market , By Product Type:
Diagnostics
Therapeutics
Precision Oncology Market , By Cancer Type:
Breast Cancer
Cervical Cancer
Prostate Cancer
Lung Cancer
Precision Oncology Market , By End User:
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Healthcare Data Companies
Precision Oncology Market , By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Precision Oncology Market .
Available Customizations:
Global Precision Oncology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Precision Oncology Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Diagnostics, Therapeutics)
5.2.2. By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer)
5.2.3. By End User (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Healthcare Data Companies)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Precision Oncology Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Cancer Type
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Precision Oncology Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.1.2.2. By Cancer Type
6.3.1.2.3. By End User
6.3.2. Canada Precision Oncology Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.2.2.2. By Cancer Type
6.3.2.2.3. By End User
6.3.3. Mexico Precision Oncology Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
6.3.3.2.2. By Cancer Type
6.3.3.2.3. By End User
7. Europe Precision Oncology Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Cancer Type
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Precision Oncology Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Cancer Type
7.3.1.2.3. By End User
7.3.2. France Precision Oncology Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Cancer Type
7.3.2.2.3. By End User
7.3.3. United Kingdom Precision Oncology Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Cancer Type
7.3.3.2.3. By End User
7.3.4. Italy Precision Oncology Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Cancer Type
7.3.4.2.3. By End User
7.3.5. Spain Precision Oncology Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Cancer Type
7.3.5.2.3. By End User
8. Asia Pacific Precision Oncology Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Cancer Type
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Precision Oncology Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Cancer Type
8.3.1.2.3. By End User
8.3.2. India Precision Oncology Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Cancer Type
8.3.2.2.3. By End User
8.3.3. Japan Precision Oncology Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Cancer Type
8.3.3.2.3. By End User
8.3.4. South Korea Precision Oncology Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Cancer Type
8.3.4.2.3. By End User
8.3.5. Australia Precision Oncology Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Cancer Type
8.3.5.2.3. By End User
9. Middle East & Africa Precision Oncology Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Cancer Type
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Precision Oncology Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Cancer Type
9.3.1.2.3. By End User
9.3.2. UAE Precision Oncology Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Cancer Type
9.3.2.2.3. By End User
9.3.3. South Africa Precision Oncology Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Cancer Type
9.3.3.2.3. By End User
10. South America Precision Oncology Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Cancer Type
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Precision Oncology Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Cancer Type
10.3.1.2.3. By End User
10.3.2. Colombia Precision Oncology Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Cancer Type
10.3.2.2.3. By End User
10.3.3. Argentina Precision Oncology Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Cancer Type
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Precision Oncology Market : SWOT Analysis
